Education

  • Loyola University, BS, 2006, Biology, Chemistry
  • Johns Hopkins University, MD, PhD, 2015, Medicine, Immunology
  • University of California San Francisco, Residency, 2017, Internal Medicine
  • University of California San Francisco, Fellowship, Hematology/Oncology

Honors & Awards

  • 2020
    UCSF Exceptional Physician Award Honorable Mention
  • 2020
    ANCO (Association of Northern California Oncologists) Travel Award
  • 2020
    ASCO Conquer Cancer Foundation Young Investigator Award
  • 2020
    Society for Translational Oncology Fellows’ Forum, selected participant
  • 2019
    Scholar-in-Training Award, AACR Annual Meeting 2019
  • 2018-2019
    UCSF Fellowship Leadership Cohort 
  • 2018, 2019
    Immunology T32 training grant recipient
  • 2018
    UCSF Academy of Medical Educators Innovations Funding for Education Grant Awardee 
  • 2018
    AACR Molecular Biology in Clinical Oncology course participant 
  • 2017
    UCSF Excellence and Innovation Award in Graduate Medical Education for developing WILD (Women in Leadership Development) annual symposium

Selected Publications

  1. Keenan BP, VAN Loon K, Khilnani AD, Fidelman N, Behr SC, Atreya CE, Oh DY. Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy. Anticancer Res. 2021 Jun; 41(6):2985-2992.  View on PubMed
  2. Keenan B, Jagsi R, Van Loon K. Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology. JAMA Oncol. 2021 06 01; 7(6):825-826.  View on PubMed
  3. Keenan BP, Kelley RKK. Key challenges for drugs in clinical development for cholangiocarcinoma. Expert Opin Investig Drugs. 2021 Apr; 30(4):285-290.  View on PubMed
  4. Keenan BP, Fong L. Conditional Cancer Immunotherapy as a Safer Way to Step on the Gas. Cancer Discov. 2021 01; 11(1):20-22.  View on PubMed
  5. Santhosh L, Harleman E, Venado A, Farrand E, E Gilbreth M, Keenan BP, Thompson VV, Shah RJ. Strategies for forming effective women's groups. Clin Teach. 2021 Apr; 18(2):126-130.  View on PubMed
  6. Santhosh L, Keenan BP, Jain S. The "Third Shift": A Path Forward to Recognizing and Funding Gender Equity Efforts. J Womens Health (Larchmt). 2020 11; 29(11):1359-1360.  View on PubMed
  7. Chu NJ, Anders RA, Fertig EJ, Cao M, Hopkins AC, Keenan BP, Popovic A, Armstrong TD, Jaffee EM, Zimmerman JW. Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development. Cancer Prev Res (Phila). 2020 07; 13(7):569-582.  View on PubMed
  8. Keenan BP, Fong L, Kelley RK. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer. 2019 10 18; 7(1):267.  View on PubMed
  9. Lowery MA, Goff LW, Keenan BP, Jordan E, Wang R, Bocobo AG, Chou JF, O'Reilly EM, Harding JJ, Kemeny N, Capanu M, Griffin AC, McGuire J, Venook AP, Abou-Alfa GK, Kelley RK. Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer. 2019 Dec 15; 125(24):4426-4434.  View on PubMed
  10. Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241.  View on PubMed
  11. Keenan B, Santhosh L, Thompson V, Harleman E. The Complex Problem of Women Trainees in Academic Medicine. J Hosp Med. 2019 03; 14(3):186-188.  View on PubMed
  12. Bridget Keenan, Madeline J Griffith, Kelly Bauer, Paige M. Bracci, Spencer Behr, Sarah E Umetsu, John Dozier Gordan, Zoe Ngo, Syma Iqbal, Diana L. Hanna, Alan P. Venook, Anthony B. El-Khoueiry, Lawrence Fong, Robin Kate Kelley. Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO). Journal of Clinical Oncology. 2019 Feb 1; 37(4_suppl):tps464-tps464.  View on PubMed
  13. Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Sarah E Umetsu, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong. Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses. Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):4087-4087.  View on PubMed
  14. Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Alexander Cheung, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong. Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC). Journal of Clinical Oncology. 2018 Feb 1; 36(4_suppl):386-386.  View on PubMed
  15. Keenan BP, Yalamanchi S, Hsu S, Norsworthy K, Brown TT. True, True, Related? Autoimmune Polyglandular Syndrome Type II. Am J Med. 2016 Jan; 129(1):38-41.  View on PubMed
  16. Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG, Dubensky TW, Hassan R, Armstrong TD, Jaffee EM. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology. 2014 Jun; 146(7):1784-94.e6.  View on PubMed
  17. Keenan BP, Jaffee EM, Armstrong TD. Tumor immunology: multidisciplinary science driving basic and clinical advances. Cancer Immunol Res. 2013 Jul; 1(1):16-23.  View on PubMed
  18. Keenan B, Jaffee EM. Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance. Ann N Y Acad Sci. 2013 May; 1284:12-6.  View on PubMed
  19. Keenan BP, Jaffee EM. Whole cell vaccines--past progress and future strategies. Semin Oncol. 2012 Jun; 39(3):276-86.  View on PubMed
  20. Keenan BP, Abuav R. Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme. Arch Dermatol. 2010 May; 146(5):577.  View on PubMed

Go to UCSF Profiles, powered by CTSI